Form 8-K · Current report
Medtronic 8-K, filed Oct 19, 2026
- Filed
- CIK
- 0001613103
- Accession no.
- 0001628280-26-066291
Summary
Medtronic completed its separation of MiniMed Group, Inc. and appointed Michael Marinaro as President, Medtronic, while shareholders at its annual general meeting elected twelve directors and approved PricewaterhouseCoopers LLP as auditor and executive compensation. The MiniMed separation followed an exchange offer for 252,813,348 MiniMed shares that was 5.4x subscribed.
Key points
- Medtronic completed the separation of MiniMed Group, Inc., after exchanging all 252,813,348 of its remaining MiniMed shares in an exchange offer that was 5.4x subscribed.
- Medtronic's board appointed Michael Marinaro as President, Medtronic, effective Oct. 14, 2026; he retains his current responsibilities and gains oversight of Greater China operations, reporting to Chairman and CEO Geoffrey S. Martha.
- Medtronic set Marinaro's fiscal 2027 base salary at $1,000,000 and approved supplemental long-term incentive awards with an aggregate target value of about $3.25 million.
- At Medtronic's annual general meeting, shareholders elected twelve directors, ratified PricewaterhouseCoopers LLP as auditor for fiscal 2027, approved named executive officer compensation, and authorized overseas market purchases of Medtronic shares.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
- 5.07Submission of Matters to a Vote of Security Holders
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On October 15, 2026, the Board of Directors (the "Board") of Medtronic plc (the “Company”) approved the appointment of Michael Marinaro, Executive Vice President and President, Medical Surgical Portfolio, Americas, and Global Commercial Operations to the role of President, Medtronic, effective October 14, 2026. In this expanded role, Mr. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.